The OTC issue is dependent on the red tapes that p

The OTC issue is dependent on the red tapes that plague OTC itself.
February 5, 2018
Dear Shareholders,
This past week we have had several inquiries on the content strategy for the
UltraFlix product line. The focus for the first two weeks of the new management
team has been to work with our funding partners to close out the current round
of funding, identifying and reaching out to resolve all outstanding corporate
issues, and completing the identification and hiring of key team members in order
to have a successful implementation of our go forward strategy.
Our goal is to resolve all of the outstanding issues by the end of the month
including payoff of all previous settlements as well as closure and payoff of any
outstanding contract disputes. We also intend to have the OTC issues cleared by
the end of the month allowing us to have no limitations or restrictions on the
company, management team or the shareholders.
The UltraFlix team is working on identifying and acquiring the most optimal
content for the platform as well as releasing updates to the current library. The
4K Studios team is focusing on the HDR go forward strategy. The UMG team is
focused on implementing our 4K 24/7 linear channels.
Finally, we have been working with a new management team at NTGL to resolve
the outstanding asset purchase agreement that we have with NTGL. NTEK
currently has 120M NTGL shares in the NTGL treasury that we allocated for the
purchase of the gaming assets from NTEK. We believe that we will have this issue
resolved this quarter. We have agreed to receive a cash payment in the amount
of the asset purchase in lieu of the shares giving NTEK and it’s shareholders the
value originally negotiated for those assets.